Literature DB >> 2581891

Expression of an HLA-Bw6-related specificity by the HLA-Cw3 molecule.

C Layet, T Delovitch, P Ferrier, D H Caillol, B R Jordan, F A Lemonnier.   

Abstract

Radioimmunoassay of HLA-transformed mouse L cells expressing A3, A24, B7, or Cw3 HLA class I molecules with a set of monomorphic monoclonal antibodies distinguishes between A3-A24 and B7-Cw3 patterns of reactivity. Analyses with Bw6-specific monoclonal antibodies and a human alloantiserum demonstrate the expression by the HLA-Cw3 molecules of a Bw6 public specificity related to but not identical with that expressed by the HLA-B7 molecules. Exon-shuffling experiments and inhibition studies of monoclonal antibody cell-surface fixation indicate that similar parts of B7 and Cw3 molecules account for their serological cross-reactivity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581891     DOI: 10.1007/bf00430930

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  30 in total

1.  Transformation of LMTK- cells with purified HLA class I gene. VI. Serological characterization of HLA-B7 and AW24 molecules.

Authors:  C Layet; P P Le Bouteiller; C N'guyen; P Mercier; F Rosa; M Fellous; D H Caillol; B R Jordan; F A Lemonnier
Journal:  Hum Immunol       Date:  1984-09       Impact factor: 2.850

2.  A monoclonal antibody directed against the HLA-Bw6 epitope.

Authors:  S F Radka; D D Kostyu; D B Amos
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

3.  Expression of human class I histocompatibility antigens at the surface of DNA-transformed mouse L cells.

Authors:  F A Lemonnier; M Malissen; P Golstein; P Le Bouteiller; N Rebai; M Damotte; D Birnbaum; D Caillol; J Trucy; B R Jordan
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

4.  HLA-B specificities and w4, w6 specificities are on the same polypeptide.

Authors:  J Ayres; P Cresswell
Journal:  Eur J Immunol       Date:  1976-11       Impact factor: 5.532

5.  A new dominant hybrid selective marker for higher eukaryotic cells.

Authors:  F Colbère-Garapin; F Horodniceanu; P Kourilsky; A C Garapin
Journal:  J Mol Biol       Date:  1981-07-25       Impact factor: 5.469

6.  Monoclonal antibody against cell surface glycoprotein of neurons.

Authors:  M Hirn; M Pierres; H Deagostini-Bazin; M Hirsch; C Goridis
Journal:  Brain Res       Date:  1981-06-15       Impact factor: 3.252

7.  HLA class I genes integrated into murine cells are inducible by interferon.

Authors:  F Rosa; P P Le Bouteiller; A Abadie; Z Mishal; F A Lemonnier; D Bourrel; M Lamotte; J Kalil; B Jordan; M Fellous
Journal:  Eur J Immunol       Date:  1983-06       Impact factor: 5.532

8.  Transformation of murine LMTK- cells with purified HLA class I genes. I. Modification of conformation of murine beta 2-microglobulin upon its association with HLA heavy chains.

Authors:  F A Lemonnier; P P Le Bouteiller; B Malissen; P Golstein; M Malissen; Z Mishal; D H Caillol; B R Jordan; F M Kourilsky
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

9.  Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes.

Authors:  S Y Yang; Y Morishima; N H Collins; T Alton; M S Pollack; E J Yunis; B Dupont
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

10.  Complete nucleotide sequence of a functional class I HLA gene, HLA-A3: implications for the evolution of HLA genes.

Authors:  T Strachan; R Sodoyer; M Damotte; B R Jordan
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598

View more
  2 in total

1.  Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51.

Authors:  M Sekimata; H Hayashi; S Nakayama; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.

Authors:  C A Müller; G Engler-Blum; V Gekeler; I Steiert; E Weiss; H Schmidt
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.